Literature DB >> 20464672

Infrapopliteal run-off and the outcome of femoropopliteal percutaneous transluminal angioplasty.

V Salapura1, A Blinc, M Kozak, M K Jezovnik, M Pohar Perme, P Berden, D Kuhelj, T Kljucevsek, P Popovic, M Stankovic, M Vrtovec, M Surlan.   

Abstract

BACKGROUND: The outcome of percutaneous transluminal angioplasty (PTA) of peripheral arterial lesions is influenced by several factors, including the haemodynamic conditions. Our study tested: (a) whether infrapopliteal run-off after completed PTA influenced the time course of restenosis/reocclusion of the femoropopliteal arterial segment, and (b) whether worsening of infrapopliteal run-off influenced the long-term femoropopliteal patency after PTA. PATIENTS AND METHODS: Among 245 patients treated by femoropopliteal PTA we enrolled 176 patients who consented to regular follow-up. Concomitant infrapopliteal PTA was performed whenever feasible. The technical success of PTA and the patency of calf arteries were assessed by angiography. Infrapopliteal run-off was scored by a modification of the Society for Vascular Surgery criteria. The treated patients' limbs were divided into a group with good infrapopliteal run-off and a group with compromised run-off. Follow-up examination of the femoropopliteal arterial segment was performed by vascular ultrasonography (US) 1, 6 and 12 months after PTA, and an adverse outcome was defined by a > or = 50 % stenosis, i.e., at least doubling of the maximal systolic velocity, or occlusion - evidenced by the absence of flow. The patency of calf arteries was re-assessed by US 12 months after PTA.
RESULTS: One month after femoropopliteal PTA 19 / 83 (23 %) of patients with compromised run-off developed the combined end-point of restenosis or reocclusion in comparison to 10 / 93 (11 %) with good run-off (p = 0.03). After 6 months the incidence of restenosis/reocclusion had increased in both groups at an approximately equal rate, but the differences were no longer significant: 39 / 80 (49 %) in the compromised run-off group vs. 36 / 83 (43 %) in the good run-off group after 6 months, p = 0.49, and 42 / 73 (57 %) vs. 38 / 73 (52 %) after 12 months, p = 0.51. However, in patients' limbs with good periprocedural run-off that deteriorated into compromised run-off in the year after PTA, femoropopliteal restenosis/reocclusion occurred more often than in limbs which retained good run-off: 10 / 14 (71 %) vs. 18 / 51 (35 %), p = 0.02.
CONCLUSIONS: Compromised postprocedural infrapopliteal run-off predisposes to early restenosis/reocclusion after femoropopliteal PTA. Deterioration of infrapopliteal run-off in the year after femoropopliteal PTA is accompanied by worsening of long-term femoropopliteal patency.

Entities:  

Mesh:

Year:  2010        PMID: 20464672     DOI: 10.1024/0301-1526/a000022

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  5 in total

1.  [Long-term results after balloon angioplasty of crural arteries. Which factors influence leg salvage and survival rates?].

Authors:  I K Tesdal; C K Krzemien; C Weiss
Journal:  Radiologe       Date:  2016-03       Impact factor: 0.635

Review 2.  An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.

Authors:  Nicolas W Shammas
Journal:  Int J Angiol       Date:  2013-03

3.  Slovenian experience from diagnostic angiography to interventional radiology.

Authors:  Dusan Pavcnik
Journal:  Radiol Oncol       Date:  2014-11-05       Impact factor: 2.991

4.  Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results.

Authors:  Yue-Xin Chen; Wen-Da Wang; Xiao-Jun Song; Yong-Quan Gu; Hong-Yan Tian; He-Jie Hu; Ji-Chun Zhao; Xiao-Qiang Li; Chang-Wei Liu
Journal:  Chin Med J (Engl)       Date:  2015-06-20       Impact factor: 2.628

5.  Impact of calcification and infrapopliteal outflow on the outcome of endovascular treatment of femoropopliteal occlusive disease.

Authors:  Rafael de Athayde Soares; Marcelo Fernando Matielo; Francisco Cardoso Brochado Neto; Ana Paula Maia Pires; Rogério Duque de Almeida; Murilo de Jesus Martins; Roberto Sacilotto
Journal:  JRSM Cardiovasc Dis       Date:  2019-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.